In China, more than 60% of consumers consider health to be the top priority in their daily lives; Compared to a year ago, they are paying more attention to their health. More notably, people are willing to increase health-related spending if overall consumption levels decline.

As China continues to prioritise health and innovation, Nansha District of Guangzhou is emerging as a burgeoning hub of biomedical industry. Building on the momentum of the "Overall development plan of Nansha, Guangzhou," Nansha district is leveraging favorable policies to become a key player in the biomedical sector.

In April 2024, Nansha released the "Support Measures for Promoting the High-quality Development of the Biomedicine Industry in Guangzhou Nansha," supporting the development of Nansha biomedicine companies in areas such as clinical trials and scenario applications. In September 2024, the Ministry of Commerce, the National Health Commission, and the National Medical Products Administration issued a notice to launch a pilot program for expanded openness in the medical field. In regions like the China (Guangdong) Pilot Free Trade Zone, foreign enterprises are allowed to engage in the development and application of human stem cell, gene diagnosis and therapeutic technologies for product registration, launch, and production. Additionally, wholly foreign-owned hospitals are permitted to be established in cities such as Guangzhou. These significant measures have been rolled out in succession, accelerating the aggregation and realisation of high-level opening-up development achievements in Guangzhou Nansha.

This event aims to showcase Nansha’s unique development opportunities and growth potential, highlighting recent industry developments and fostering strategic collaboration between the Yangtze River Delta, the Greater Bay Area, and global markets. This event is a prime opportunity for biomedical enterprises to engage with Nansha’s dynamic business environment, supported by robust policies and a commitment to innovation. We are inviting Guangzhou Municipal Health Commission, Guangzhou Municipal Commerce Bureau, Guangzhou Municipal Healthcare Securities Bureau, Office of Canton Investment Development Commission and People's Government of Nansha District.

Advisory Council Policy

Members of the Advisory Council may receive complimentary admission to Chamber seminars and conferences up to two attendees per event. Additional participants will be charged at the member rate.

Advisory Council members will still be charged the standard member rate for participation in training courses and special events, such as gala balls, government appreciation dinners, exclusive tours or admission to corporate social events/tournaments.

For further information contact Mengting Dai mtdai@europeanchamber.com.cn

Terms & Conditions

Events have limited seating so to ensure your attendance we encourage advance online registration and payment. We cannot guarantee entry to anyone not registered in advance.

- Members can pay via wechat QR code once registered.

- Non-members will receive an email with a payment code shortly.

Fapiao will be mailed to you within 5-10 working days after the event. 

Cancellation Policy

If you cannot attend the event for which you have registered, please cancel your registration no later than one business day prior to the event. If you fail to notify us of your cancellation in a timely fashion, you will be charged for event costs.

To cancel you can: 1) email yangzhao@europeanchamber.com.cn, or 2) cancel online if you registered for the event through the website.

Disclaimer

Please notice that European Union Chamber of Commerce in China might take photographs from the event and post these on its public web-page (or social media platforms) in order to create awareness of these events. By attending this event you consent to European Union Chamber of Commerce in China taking and using such photographs as described above.

Related

Contact